Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models

Background To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer. Methods A total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrospectively. Rectal MR images were scanned pre- and post-nCRT. The radiomics features were extracted from T2-weighted images, then reduced separately by least absolute shrinkage and selection operator (LASSO) and principal component analysis (PCA). Four classifiers of Logistic Regression, Random Forest (RF), Decision Tree and K-nearest neighbor (KNN) models were constructed to assess the tumor regression grade (TRG) and pathologic complete response (pCR), respectively. The diagnostic performances of models were determined with leave-one-out cross-validation by generating receiver operating characteristic curves and decision curve analysis. Results Three features related to the TRG and 11 features related to the pCR were obtained by LASSO. Top five principal components representing a cumulative contribution of 80% to overall features were selected by PCA. For TRG, the area under the curve (AUC) of RF model was 0.943 for LASSO and 0.930 for PCA, higher than other models ( P  < 0.05 for both). As for pCR, the AUCs of KNN for LASSO and PCA were 0.945 and 0.712, higher than other models ( P  < 0.05 for both). The DCA showed that LASSO algorithm was clinically superior to PCA. Conclusion MRI-based radiomics models demonstrated good performance for evaluating the treatment response of LARC after nCRT and LASSO algorithm yielded more clinical benefit.

[1]  Xiaotang Yang,et al.  Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer , 2018, European Radiology.

[2]  Jie Tian,et al.  Radiomics-Based Preoperative Prediction of Lymph Node Status Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer , 2020, Frontiers in Oncology.

[3]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[4]  Hein Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. , 2011, The Lancet. Oncology.

[5]  Yanqi Huang,et al.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Xiaoyan Zhang,et al.  Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. , 2020, Radiology.

[7]  Yan Jia,et al.  MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features , 2019, BMC Medical Imaging.

[8]  Jiazhou Wang,et al.  Reproducibility with repeat CT in radiomics study for rectal cancer , 2016, Oncotarget.

[9]  Huimao Zhang,et al.  A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer , 2020, Frontiers in Oncology.

[10]  H. Aerts,et al.  Deep Learning for Fully-Automated Localization and Segmentation of Rectal Cancer on Multiparametric MR , 2017, Scientific Reports.

[11]  Di Dong,et al.  The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer , 2016, Oncotarget.

[12]  Gustavo S. França,et al.  Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. , 2015, Cancer genetics.

[13]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[14]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[15]  H. Heneghan,et al.  Systematic review and meta‐analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer , 2012, The British journal of surgery.

[16]  T. Reid,et al.  Locally advanced rectal cancer: The past, present, and future. , 2020, Seminars in oncology.

[17]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[18]  T. Niu,et al.  Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI , 2016, Clinical Cancer Research.

[19]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[20]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[21]  H. Aerts,et al.  Applications and limitations of radiomics , 2016, Physics in medicine and biology.

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[23]  Karin Haustermans,et al.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.

[24]  Zhengrong Liang,et al.  Volumetric texture features from higher-order images for diagnosis of colon lesions via CT colonography , 2014, International Journal of Computer Assisted Radiology and Surgery.

[25]  W. Price,et al.  Privacy in the age of medical big data , 2019, Nature Medicine.

[26]  N. Nakamura,et al.  MR Imaging with Apparent Diffusion Coefficient Histogram Analysis: Evaluation of Locally Advanced Rectal Cancer after Chemotherapy and Radiation Therapy. , 2018, Radiology.

[27]  Ahmed Kamel,et al.  Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[28]  Damiano Caruso,et al.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer , 2017, Oncotarget.

[29]  Liangliang Wang,et al.  Functional principal component analysis of glomerular filtration rate curves after kidney transplant , 2018, Statistical methods in medical research.

[30]  Huan Liu,et al.  Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2020, Frontiers in Oncology.

[31]  Ahmed Hosny,et al.  Artificial intelligence in radiology , 2018, Nature Reviews Cancer.

[32]  Dan Wang,et al.  Predicting pathological complete response by comparing MRI‐based radiomics pre‐ and postneoadjuvant radiotherapy for locally advanced rectal cancer , 2019, Cancer medicine.

[33]  S. Park,et al.  MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy , 2020, European Radiology.

[34]  Zhenchao Tang,et al.  Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer , 2017, Clinical Cancer Research.

[35]  Jiazhou Wang,et al.  Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings , 2018, Journal of magnetic resonance imaging : JMRI.

[36]  Caroline Reinhold,et al.  The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"? , 2013, Radiology.

[37]  Yan Jia,et al.  MRI-Based Radiomics of Rectal Cancer: Assessment of the Local Recurrence at the Site of Anastomosis. , 2020, Academic radiology.

[38]  Gina Brown,et al.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.